Prevención en salud: ¿inversión rentable? Eficiencia económica de las intervenciones preventivas en España

Esperato, Alexo; García-Altés, Anna

doi:10.1157/13101044

Cited by 13 publications

(4 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…was the first to explore research priorities for a specific type of economic evaluation in healthcare: cost-utility analyses. However, none of the systematic reviews of the use of economic evaluation published have approached this issue in Southern European countries such as Spain [1,2,11,12]. …”

Section: Introductionmentioning

confidence: 99%

Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters?

Catalá-López

García-Altés

Álvarez-Martín

et al. 2011

BMC Health Serv Res

Self Cite

View full text Add to dashboard Cite

BackgroundThe allocation of limited available healthcare resources demands an agreed rational allocation principle and the consequent priority setting. We assessed the association between economic evaluations of healthcare interventions published in Spain (1983-2008) and the disease burden in the population.MethodsElectronic databases (e.g., PubMed/MEDLINE, SCOPUS, ISI Web of Knowledge, CRD, IME, IBECS) and reports from health technology assessment agencies were systematically reviewed. For each article, multiple variables were recorded such as: year and journal of publication, type of study, health intervention targetted, perspective of analysis, type of costs and sources of information, first author's affiliation, explicit recommendations aimed at decision-making, and the main disease cause to which the intervention was addressed. The following disease burden measures were calculated: years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years (DALYs), and mortality by cause. Correlation and linear regression models were fitted.ResultsFour hundred and seventy-seven economic evaluations were identified. Cardiovascular diseases (15.7%), infectious diseases (15.3%), malignant neoplasms (13.2%), and neuropsychiatric diseases (9.6%) were the conditions most commonly addressed. Accidents and injuries, congenital anomalies, oral conditions, nutritional deficiencies and other neoplasms were the categories with a lowest number of studies (0.6% for each of them). For the main disease categories (n = 20), a correlation was seen with: mortality 0.67 (p = 0.001), DALYs 0.63 (p = 0.003), YLLs 0.54 (p = 0.014), and YLDs 0.51 (p = 0.018). By disease sub-categories (n = 51), the correlations were generally low and non statistically significant.ConclusionsExamining discrepancies between economic evaluations in particular diseases and the overall burden of disease helps shed light on whether there are potentially over- and under-investigated areas. The approach taken could help policy-makers understand whether resources for economic evaluation are being allocated by using summary measures of population health.

show abstract

Section: Introductionmentioning

confidence: 99%

Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters?

Catalá-López

García-Altés

Álvarez-Martín

et al. 2011

BMC Health Serv Res

Self Cite

View full text Add to dashboard Cite

show abstract

“…En el apartado de evaluación económica, se incluyeron términos referidos a los tipos de evaluación económica y términos generales de economía de la salud. Para el apartado de ámbito geográfico, la búsqueda se fundamentó en una estrategia previamente validada 8,9 . La lista completa de términos utilizados figura en el Anexo.…”

Section: Fuentes De Informaciónunclassified

Evaluación económica de intervenciones sanitarias en España durante el periodo 1983-2008

Catalá-López¹,

García-Altés²

2010

Rev. Esp. Salud Publica

Self Cite

View full text Add to dashboard Cite

show abstract

“…En el caso españ ol, la capacidad de influencia en la política real de investigadores y profesionales es especialmente reducida, en parte porque é stos tienden a ignorar la dimensió n política de los problemas de salud y de las soluciones propuestas 18 . Los políticos buscan soluciones aplicables y, a ser posible, de eficiencia y efectividad contrastadas, y desafortunadamente las evaluaciones de coste-efectividad son má s abundantes en el á rea de la prevenció n )medicalizada* que en otras estrategias preventivas 19 . En la cultura administrativa españ ola, los procesos de rendició n de cuentas está n poco arraigados, aunque se van produciendo algunos avances.…”

Section: Puntos Fuertes Y Dé Biles En Españ Aunclassified

La salud en todas las políticas. Tiempo de crisis, ¿tiempo de oportunidades? Informe SESPAS 2010

Urbanos¹

2010

Gaceta Sanitaria

View full text Add to dashboard Cite

A cost-effective and equitable health policy design involves tackling social determinants of health and becoming aware of the impact of non-healthcare policies. Structural changes in institutional organization, targeted to create a new space for network governance, are required. Some factors tend to delay this process, such as institutional inertia, poor coordination and cooperation mechanisms among sectors, levels of government and agents, the consolidation of the biomedical paradigm reinforced by lobbies and cultural patterns, and inadequate collaboration among experts, practitioners and health authorities. However, these factors may be counterbalanced by political will and by the knowledge provided by domestic and foreign experiences. The present situation arising from the recent public health crises, and particularly from the current economic depression, offers a major chance to introduce the needed changes in health oriented actions.

show abstract

Prevención en salud: ¿inversión rentable? Eficiencia económica de las intervenciones preventivas en España

Cited by 13 publications

References 38 publications

Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters?

Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters?

Evaluación económica de intervenciones sanitarias en España durante el periodo 1983-2008

La salud en todas las políticas. Tiempo de crisis, ¿tiempo de oportunidades? Informe SESPAS 2010

Contact Info

Product

Resources

About